Combinatorial chemistry. Facing the challenge of chemical genomics

Ferenc Darvas, Gyorgy Dorman, Laszlo Urge, Istvan Szabo, Z. Rónai, M. Sasvári

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

In the age of high-throughput screening and combinatorial chemistry, the focus of drug discovery is to replace the sequential approach with the most effective parallel approach. By the completion of the human gene-map, understanding and healing a disease require the integration of genomics, proteomics, and, very recently, metabolomics with early utilization of diverse small-molecule libraries to create a more powerful "total" drug discovery approach. In this post-genomic era, there is an enhanced demand for information-enriched combinatorial libraries which are high-quality, chemically and physiologically stable, diverse, and supported by measured and predicted data. Furthermore, specific marker libraries could be used for early functional profiling of the genome, proteome, and metabolome. In this new operating model, called "combinatorial chemical genomics", an optimal combination of the marker and high-quality libraries provides a novel synergy for the drug discovery process at a very early stage.

Original languageEnglish
Pages (from-to)1487-1498
Number of pages12
JournalPure and Applied Chemistry
Volume73
Issue number9
Publication statusPublished - 2001

Fingerprint

Genes
Proteome
Screening
Throughput
Proteins
Molecules
Drug Discovery
Genomics
Proteomics
Metabolomics

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

Combinatorial chemistry. Facing the challenge of chemical genomics. / Darvas, Ferenc; Dorman, Gyorgy; Urge, Laszlo; Szabo, Istvan; Rónai, Z.; Sasvári, M.

In: Pure and Applied Chemistry, Vol. 73, No. 9, 2001, p. 1487-1498.

Research output: Contribution to journalArticle

Darvas, F, Dorman, G, Urge, L, Szabo, I, Rónai, Z & Sasvári, M 2001, 'Combinatorial chemistry. Facing the challenge of chemical genomics', Pure and Applied Chemistry, vol. 73, no. 9, pp. 1487-1498.
Darvas, Ferenc ; Dorman, Gyorgy ; Urge, Laszlo ; Szabo, Istvan ; Rónai, Z. ; Sasvári, M. / Combinatorial chemistry. Facing the challenge of chemical genomics. In: Pure and Applied Chemistry. 2001 ; Vol. 73, No. 9. pp. 1487-1498.
@article{7001e3911e3046da8e1159054aa984e8,
title = "Combinatorial chemistry. Facing the challenge of chemical genomics",
abstract = "In the age of high-throughput screening and combinatorial chemistry, the focus of drug discovery is to replace the sequential approach with the most effective parallel approach. By the completion of the human gene-map, understanding and healing a disease require the integration of genomics, proteomics, and, very recently, metabolomics with early utilization of diverse small-molecule libraries to create a more powerful {"}total{"} drug discovery approach. In this post-genomic era, there is an enhanced demand for information-enriched combinatorial libraries which are high-quality, chemically and physiologically stable, diverse, and supported by measured and predicted data. Furthermore, specific marker libraries could be used for early functional profiling of the genome, proteome, and metabolome. In this new operating model, called {"}combinatorial chemical genomics{"}, an optimal combination of the marker and high-quality libraries provides a novel synergy for the drug discovery process at a very early stage.",
author = "Ferenc Darvas and Gyorgy Dorman and Laszlo Urge and Istvan Szabo and Z. R{\'o}nai and M. Sasv{\'a}ri",
year = "2001",
language = "English",
volume = "73",
pages = "1487--1498",
journal = "Pure and Applied Chemistry",
issn = "0033-4545",
publisher = "IUPAC Secretariat",
number = "9",

}

TY - JOUR

T1 - Combinatorial chemistry. Facing the challenge of chemical genomics

AU - Darvas, Ferenc

AU - Dorman, Gyorgy

AU - Urge, Laszlo

AU - Szabo, Istvan

AU - Rónai, Z.

AU - Sasvári, M.

PY - 2001

Y1 - 2001

N2 - In the age of high-throughput screening and combinatorial chemistry, the focus of drug discovery is to replace the sequential approach with the most effective parallel approach. By the completion of the human gene-map, understanding and healing a disease require the integration of genomics, proteomics, and, very recently, metabolomics with early utilization of diverse small-molecule libraries to create a more powerful "total" drug discovery approach. In this post-genomic era, there is an enhanced demand for information-enriched combinatorial libraries which are high-quality, chemically and physiologically stable, diverse, and supported by measured and predicted data. Furthermore, specific marker libraries could be used for early functional profiling of the genome, proteome, and metabolome. In this new operating model, called "combinatorial chemical genomics", an optimal combination of the marker and high-quality libraries provides a novel synergy for the drug discovery process at a very early stage.

AB - In the age of high-throughput screening and combinatorial chemistry, the focus of drug discovery is to replace the sequential approach with the most effective parallel approach. By the completion of the human gene-map, understanding and healing a disease require the integration of genomics, proteomics, and, very recently, metabolomics with early utilization of diverse small-molecule libraries to create a more powerful "total" drug discovery approach. In this post-genomic era, there is an enhanced demand for information-enriched combinatorial libraries which are high-quality, chemically and physiologically stable, diverse, and supported by measured and predicted data. Furthermore, specific marker libraries could be used for early functional profiling of the genome, proteome, and metabolome. In this new operating model, called "combinatorial chemical genomics", an optimal combination of the marker and high-quality libraries provides a novel synergy for the drug discovery process at a very early stage.

UR - http://www.scopus.com/inward/record.url?scp=0035743525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035743525&partnerID=8YFLogxK

M3 - Article

VL - 73

SP - 1487

EP - 1498

JO - Pure and Applied Chemistry

JF - Pure and Applied Chemistry

SN - 0033-4545

IS - 9

ER -